KRAS and colorectal carcinoma: In 2021, these statements were supported by previous data of our laboratory displaying that, in fact, ascorbic acid induces HIF1α degradation, leading to reduced GLUT1 and PDK1 expression, finally increasing PDH activity in KRAS mutant CRC [16].